Expert Review Of Gastroenterology & Hepatology SCIE

國(guó)際簡(jiǎn)稱：EXPERT REV GASTROENT 參考譯名：胃腸病學(xué)和肝病學(xué)專家評(píng)論

主要研究方向：GASTROENTEROLOGY & HEPATOLOGY 非預(yù)警期刊審稿周期：較慢,6-12周

《胃腸病學(xué)和肝病學(xué)專家評(píng)論》(Expert Review Of Gastroenterology & Hepatology)是一本由Taylor and Francis Ltd.出版的以GASTROENTEROLOGY & HEPATOLOGY為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
109 年發(fā)文量
3.8 IF影響因子
未開放 是否OA
41 H-index
2007 創(chuàng)刊年份
8 issues/year 出版周期
English 出版語(yǔ)言

The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.

[ 查看全部 ]

投稿咨詢加急咨詢

Expert Review Of Gastroenterology & Hepatology期刊信息

ISSN：1747-4124
出版語(yǔ)言：English
是否OA：未開放
E-ISSN：1747-4132
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Taylor and Francis Ltd.
出版周期：8 issues/year
創(chuàng)刊時(shí)間：2007
開源占比：0.071
Gold OA文章占比：10.34%
OA被引用占比：0.0243...
出版國(guó)人文章占比：0.14
出版撤稿占比：0
研究類文章占比：22.02%

Expert Review Of Gastroenterology & Hepatology CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

6.8

1.09

0.975

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Gastroenterology	Q1	31 / 167	81%
大類：Medicine 小類：Hepatology	Q2	25 / 82	70%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Expert Review Of Gastroenterology & Hepatology中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	4區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	4區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	4區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	4區(qū)

Expert Review Of Gastroenterology & Hepatology JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	37 / 143	74.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	65 / 143	54.9%

Expert Review Of Gastroenterology & Hepatology歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Expert Review Of Gastroenterology & Hepatology中國(guó)學(xué)者發(fā)文選摘

1、Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis
Author: Tian, Bao-Wen; Yan, Lun-Jie; Ding, Zi-Niu; Liu, Hui; Meng, Guang-Xiao; Xue, Jun-Shuai; Han, Cheng-Long; Dong, Zhao-Ru; Hong, Jian-Guo; Chen, Zhi-Qiang; Wang, Dong-Xu; Li, Tao

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 73-83. DOI: 10.1080/17474124.2022.2156859
2、The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis
Author: Liu, Lili; Zhang, Chengren; Lu, Tingting; Li, Xiong; Jiang, Zhiliang; Tian, Hongwei; Hao, Xiangyong; Yang, Kehu; Guo, Tiankang

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 59-71. DOI: 10.1080/17474124.2023.2162878
3、Research progress on short-term prognosis of acute-on-chronic liver failure
Author: Ma, Luyao; Liu, Siqi; Xing, Hao; Jin, Zhenjing

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 45-57. DOI: 10.1080/17474124.2023.2165063
4、The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis
Author: Xu, Fangshen; Zhang, Siyao; Ye, Danni; Chen, Zheng; Ding, Jiawei; Zhang, Tao; Ren, Shenli; Zhang, Yu; Zheng, Huilin; Zhou, Jie; Hu, Zhenhua

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 215-223. DOI: 10.1080/17474124.2023.2165489
5、The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis
Author: Han, Cheng-Long; Tian, Bao-Wen; Yang, Chun-Cheng; Yang, Ya-Fei; Ma, Yun-Long; Ding, Zi-Niu; Yan, Lun-Jie; Liu, Hui; Dong, Zhao-Ru; Chen, Zhi-Qiang; Hong, Jian-Guo; Wang, Dong-Xu; Li, Tao

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 189-198. DOI: 10.1080/17474124.2023.2166930
6、CT-based radiomics nomogram for differentiating gastric hepatoid adenocarcinoma from gastric adenocarcinoma: a multicentre study
Author: Wang, Jing; Kang, Bing; Sun, Cong; Du, Fengying; Lin, Jianxian; Ding, Fanghui; Dai, Zhengjun; Zhang, Yifei; Yang, Chenggang; Shang, Liang; Li, Leping; Hong, Qingqi; Huang, Changming; Wang, Guangbin

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 205-214. DOI: 10.1080/17474124.2023.2166490
7、New progress with calcium-binding protein S100A16 in digestive system disease
Author: Li, Binbin; Zhu, Wanqing; Shi, Di; Che, Huilin; Lyu, Qinglan; Jiang, Bimei

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 3, pp. 263-272. DOI: 10.1080/17474124.2023.2174968
8、Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials
Author: Gu, Yunpeng; Sun, Lei; He, Yining; Yang, Luping; Deng, Chaohua; Zhou, Run; Kong, Tingting; Zhang, Wei; Chen, Yutong; Li, Jie; Shi, Junping

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 3, pp. 273-282. DOI: 10.1080/17474124.2023.2172397